Alterity Therapeutics Stock Price on April 26, 2024
| ATHE Stock | USD 1.07 0.02 1.90% |
Below is the normalized historical share price chart for Alterity Therapeutics extending back to September 05, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Alterity Therapeutics stands at 1.07, as last reported on the 23rd of November, with the highest price reaching 1.10 and the lowest price hitting 1.07 during the day.
If you're considering investing in Alterity Stock, it is important to understand the factors that can impact its price. Alterity Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0743, which signifies that the company had a -0.0743% return per unit of risk over the last 3 months. Alterity Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alterity Therapeutics' Risk Adjusted Performance of (0.05), mean deviation of 2.94, and Standard Deviation of 3.96 to double-check the risk estimate we provide.
At present, Alterity Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 21.8 M, whereas Common Stock is forecasted to decline to about 114 M. . At present, Alterity Therapeutics' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 1.39, whereas Price Earnings Ratio is forecasted to decline to (1.00). Alterity Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of September 2002 | 200 Day MA 1.6603 | 50 Day MA 1.2212 | Beta 0.684 |
Alterity |
Sharpe Ratio = -0.0743
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ATHE |
Estimated Market Risk
| 3.93 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Alterity Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alterity Therapeutics by adding Alterity Therapeutics to a well-diversified portfolio.
Price Book 1.0415 | Enterprise Value Ebitda 0.7546 | Price Sales 2.5487 | Shares Float 3.7 B | Wall Street Target Price 7 |
Related Headline
Vaccinex Headline on 26th of April 2024
Vaccinex files to sell 193,000 shares of common stock for ho... by seekingalpha.com
Vaccinex files prospectus for the resale of 193,000 shares of common stock. This filing is not an offer to sell.
Alterity Therapeutics Valuation on April 26, 2024
It is possible to determine the worth of Alterity Therapeutics on a given historical date. On April 26, 2024 Alterity was worth 2.26 at the beginning of the trading date compared to the closed value of 2.51. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Alterity Therapeutics stock. Still, in general, we apply an absolute valuation method to find Alterity Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alterity Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Alterity Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.30 | 2.47 | 2.26 | 2.26 | 24,785 | |
04/26/2024 | 2.26 | 2.75 | 2.26 | 2.51 | 87,873 |
| 2.48 | 2.54 | 2.00 | 2.19 | 170,887 |
| Backtest Alterity Therapeutics | | | Alterity Therapeutics History | | | Alterity Therapeutics Valuation | Previous | Next |
Alterity Therapeutics Trading Date Momentum on April 26, 2024
| On April 29 2024 Alterity Therapeutics was traded for 2.19 at the closing time. The top price for the day was 2.54 and the lowest listed price was 2.00 . The trading volume for the day was 170.9 K. The trading history from April 29, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 12.75% . The overall trading delta against the current closing price is 15.94% . |
Alterity Therapeutics Fundamentals Correlations and Trends
By evaluating Alterity Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Alterity Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Alterity financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Alterity Therapeutics Stock history
Alterity Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Alterity is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Alterity Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Alterity Therapeutics stock prices may prove useful in developing a viable investing in Alterity Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.6 B | 3.8 B | |
| Net Loss | -12.4 M | -13 M |
Alterity Therapeutics Quarterly Net Working Capital |
|
Alterity Therapeutics Stock Technical Analysis
Alterity Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Alterity Therapeutics Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Alterity Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Alterity Therapeutics November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Alterity Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alterity Therapeutics shares will generate the highest return on investment. By undertsting and applying Alterity Therapeutics stock market strength indicators, traders can identify Alterity Therapeutics entry and exit signals to maximize returns
Alterity Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Alterity Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Alterity Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Alterity to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.91) | |||
| Treynor Ratio | 0.9944 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Alterity Stock analysis
When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |